KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Accounts Payables (2016 - 2025)

Globus Medical's Accounts Payables history spans 15 years, with the latest figure at $98.9 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 31.6% year-over-year to $98.9 million; the TTM value through Dec 2025 reached $98.9 million, up 31.6%, while the annual FY2025 figure was $98.9 million, 31.6% up from the prior year.
  • Accounts Payables reached $98.9 million in Q4 2025 per GMED's latest filing, up from $87.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $98.9 million in Q4 2025 to a low of $1.5 million in Q2 2023.
  • Average Accounts Payables over 5 years is $48.5 million, with a median of $45.2 million recorded in 2023.
  • Peak YoY movement for Accounts Payables: tumbled 95.6% in 2023, then soared 4362.66% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $22.0 million in 2021, then skyrocketed by 64.43% to $36.1 million in 2022, then surged by 56.98% to $56.7 million in 2023, then soared by 32.55% to $75.1 million in 2024, then surged by 31.6% to $98.9 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Accounts Payables are $98.9 million (Q4 2025), $87.2 million (Q3 2025), and $87.1 million (Q2 2025).